000 | 01779 a2200481 4500 | ||
---|---|---|---|
005 | 20250518032521.0 | ||
264 | 0 | _c20200324 | |
008 | 202003s 0 0 eng d | ||
022 | _a1090-2104 | ||
024 | 7 |
_a10.1016/j.bbrc.2019.02.015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoshi, Taisuke | |
245 | 0 | 0 |
_aLenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _c05 2019 |
||
300 |
_a1-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblast Growth Factors _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
650 | 0 | 4 |
_aQuinolines _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, Fibroblast Growth Factor _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aWatanabe Miyano, Saori | |
700 | 1 | _aWatanabe, Hideki | |
700 | 1 | _aSonobe, Regina Mikie Kanada | |
700 | 1 | _aSeki, Yuki | |
700 | 1 | _aOhta, Etsuko | |
700 | 1 | _aNomoto, Kenichi | |
700 | 1 | _aMatsui, Junji | |
700 | 1 | _aFunahashi, Yasuhiro | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 513 _gno. 1 _gp. 1-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2019.02.015 _zAvailable from publisher's website |
999 |
_c29548649 _d29548649 |